Comparative efficacies of three commercially available vaccines against West Nile virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model

Clinical and Vaccine Immunology

Volumn 14, Issue 11, 2007, Pages 1465-1471

  Seino, K K ^a   Long, M T ^a   Gibbs, E P J ^a   Bowen, R A ^a,b   Beachboard, S E ^a   Humphrey, P P ^a   Dixon, M A ^a   Bourgeois, M A ^a  

^a University of Florida College of Veterinary Medicine   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; INACTIVATED VACCINE; LIVE VACCINE; VIRUS VECTOR; WEST NILE VACCINE;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CANARYPOX VIRUS; CONTROLLED STUDY; DRUG EFFICACY; ENCEPHALITIS; GENDER; HISTOPATHOLOGY; HORSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; STATISTICAL SIGNIFICANCE; SURVIVAL; VIREMIA; WEST NILE FLAVIVIRUS;

ANIMALS; ANTIBODIES, VIRAL; HORSE DISEASES; HORSES; WEST NILE FEVER; WEST NILE VIRUS; WEST NILE VIRUS VACCINES;

EID: 37349078256     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00249-07     Document Type: Article

References (31)

1. Animal and Plant Health Inspection Service. USDA animal health monitoring and surveillance: equine West Nile virus surveillance data. Animal and Plant Health Inspection Service, U.S. Department of Agriculture, Washington, DC. www.aphis.usda.gov/vs/nahss/equine/wnv/. Accessed 7 March 2007.
2. Beaty, B. J., C. H. Calisher, and R. E. Shope. 1989. Arboviruses, p. 797-856. In N. H. Schmidt and R. W. Emmons, Diagnostic procedures for viral, rickettsial, and chlamydial infections, 6th ed. American Public Health Association, Washington, DC.
3. Bowen, R. A., P. Gordy, M. W. Mellencamp, and D. Baker. 2004. Efficacy of a live attenuated chimeric West Nile virus vaccine in horses against clinical disease following challenge with virulent West Nile virus, abstr. 2096. Suppl. Proc. 53rd Annu. Meet. Am. J. Trop. Med. Hyg., Miami Beach, FL.
4. Bunning, M. L., R. A. Bowen, C. B. Cropp, K. G. Sullivan, B. S. Davis, N. Komar, M. S. Godsey, D. Baker, D. L. Hettler, D. A. Holmes, B. J. Biggerstaff, and C. J. Mitchell. 2002. Experimental infection of horses with West Nile virus. Emerg. Infect. Dis. 8:380-386.
5. Centers for Disease Control and Prevention. West Nile virus: statistics, surveillance, and control. Centers for Disease Control and Prevention, Atlanta, GA. www.cdc.gov/ncidod/dvbid/westnile/ surv&controlCaseCount06 _detailed.htm. Accessed 6 March 2007.
6. Davidson, A. H., J. L. Traub-Dargatz, R. M. Rodeheaver, E. N. Ostlund, D. D. Pedersen, R. G. Moorhead, J. B. Stricklin, R. D. Dewell, S. D. Roach, R. E. Long, S. J. Albers, R. J. Callan, and M. D. Salman. 2005. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J. Am. Vet. Med. Assoc. 226:240-245.
7. Diamond, M. S., B. Shrestha, E. Mehlhop, E. Sitati, and M. Engte. 2003. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 16:259-278.
8. Gardner, I. A., S. J. Wong, G. L. Ferraro, U. B. Balasuriya, P. J. Hullinger, W. D. Wilson, P. Y. Shi, and N. J. MacLachlan. 2007. Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California. Vet. Res. 38:109-116.
9. Grosenbaugh, D. A., C. S. Backus, K. Karaca, J. M. Minke, and R. M. Nordgren. 2004. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine. Vet. Ther. 5:251-257.
10. Guirakhoo, F., Z. X. Zhang, T. J. Chambers, S. Delagrave, J. Arroyo, A. D. Barrett, and T. P. Monath. 1999. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology 257:363-372.
11. Hayes, E. B. 2005. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg. Infect. Dis. 11:1174-1179.
12. + T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79:11457-11466.
13. Kumar, P., P. D. Uchil, P. Sulocbana, G. Nirmala, R. Chandrashekar, M. Haridattatreya, and V. Satchidanandam. 2003. Screening for T cell-eliciting proteins of Japanese encephalitis virus in a healthy JE-endemic human cohort using recombinant baculovirus-infected insect cell preparations. Arch. Virol. 148:1569-1591.
14. Long, M., E. Gibbs, M. Mellencamp, R. Bowen, K. Seino, S. Zhang, S. Beachboard, and P. Humphrey. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live flavivirus chimera in horses with an experimentally induced clinical disease challenge model. Equine Vet. J., in press.
15. Minke, J. M., L. Siger, K. Karaca, L. Austgen, P. Gordy, R. Bowen, R. W. Rensnaw, S. Loosmore, J. C. Audonnet, and B. Nordgren. 2004. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. Arch. Virol. Suppl. 18:221-230.
16. Monath, T. P., F. Guirakhoo, R. Nichols, S. Yoksan, R. Schrader, C. Murphy, P. Blum, S. Woodward, K. McCarthy, D. Mathis, C. Johnson, and P. Bedford. 2003. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J. Infect. Dis. 188:1213-1230.
17. Monath, T. P., I. Levenbook, K. Soike, Z. X. Zhang, M. Ratterree, K. Draper, A. D. Barrett, R. Nichols, R. Weltzin, J. Arroyo, and F. Guirakhoo. 2000. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J. Virol. 74:1742-1751.
18. Monath, T. P., J. Liu, N. Kanesa-Thasan, G. A. Myers, R. Nichols, A. Deary, K. McCarthy, C. Johnson, T. Ermak, S. Shin, J. Arroyo, F. Guirakhoo, J. S. Kennedy, F. A. Ennis, S. Green, and P. Bedford. 2006. A live, attenuated recombinant West Nile virus vaccine. Proc. Natl. Acad. Sci. USA 103:6694-6699.
19. Ostlund, E. N., R. L. Crom, D. D. Pedersen, D. J. Johnson, W. O. Williams, and B. J. Schmitt. 2001. Equine West Nile encephalitis, United States. Emerg. Infect. Dis. 7:665-669.
20. Porter, M. B., M. T. Long, L. M. German, S. Giguere, R. J. MacKay, G. D. Lester, A. R. Alleman, H. L. Wamsley, R. P. Franklin, S. Jacks, C. D. Buergelt, and C. J. Detrisac. 2003. West Nile virus encephalomyelitis in horses: 46 cases (2001). J. Am. Vet. Med. Assoc. 222:1241-1247.
21. Salazar, P., J. L. Traub-Dargatz, P. S. Morley, D. D. Wilmot, D. J. Steffen, W. E. Cunningham, and M. D. Salman. 2004. Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. J. Am. Vet. Med. Assoc. 225:267-274.
22. Savage, H. M., C. Ceianu, G. Nicolescu, N. Karabatsos, R. Lanciotti, A. Vladimirescu, L. Laiv, A. Ungureanu, C. Romanca, and T. F. Tsai. 1999. Entomologic and avian investigations of an epidemic of West Nile fever in Romania in 1996, with serologic and molecular characterization of a virus isolate from mosquitoes. Am. J. Trop. Med. Hyg. 61:600-611.
23. Schuler, L. A., M. L. Khaitsa, N. W. Dyer, and C. L. Stoltenow. 2004. Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002). J. Am. Vet. Med. Assoc. 225:1084-1089.
24. + T cells in control of West Nile virus infection. J. Virol. 78:8312-8321.
25. Siger, L., R. Bowen, K. Karaca, M. Murray, S. Jagannatha, B. Echols, R. Nordgren, and J. M. Minke. 2006. Evaluation of the efficacy provided by a recombinant canarypox-vectored equine West Nile virus vaccine against an experimental West Nile virus intrathecal challenge in horses. Vet. Ther. 7:249-256.
26. Siger, L., R. A. Bowen, K. Karaca, M. J. Murray, P. W. Gordy, S. M. Loosmore, J. C. Audonnet, R. M. Nordgren, and J. M. Minke. 2004. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses. Am. J. Vet. Res. 65:1459-1462.
27. Simmons, C. P., T. Dong, N. V. Chau, N. T. Dung, T. N. Chan, T. T. Thao le, N. T. Dung, T. T. Hien, S. Rowland-Jones, and J. Farrar. 2005. Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infections. J. Virol. 79:5665-5675.
28. Tesh, R. B., J. Arroyo, A. P. Travassos da Rosa, H. Guzman, S. Y. Xiao, and T. P. Monath. 2002. Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg. Infect. Dis. 8:1392-1397.
29. Turell, M. J., M. Bunning, G. V. Ludwig, B. Ortman, J. Chang, T. Speaker, A. Spielman, R. McLean, N. Komar, R. Gates, T. McNamara, T. Creekmore, L. Farley, and C. J. Mitchell. 2003. DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus). Emerg. Infect. Dis. 9:1077-1081.
30. Ward, M. P., M. Levy, H. L. Thacker, M. Ash, S. K. Norman, G. E. Moore, and P. W. Webb. 2004. Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses. J. Am. Vet. Med. Assoc. 225:84-89.
31. Yang, J. S., J. J. Kim, D. Hwang, A. Y. Choo, K. Dang, H. Maguire, S. Kudchodkar, M. P. Ramanathan, and D. B. Weiner. 2001. Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999). J. Infect. Dis. 184:809-816.